S&P 500   4,565.43 (+0.23%)
DOW   35,547.03 (+0.37%)
QQQ   390.93 (+0.19%)
AAPL   189.48 (-0.48%)
MSFT   378.78 (-1.02%)
META   333.51 (-1.62%)
GOOGL   135.53 (-1.22%)
AMZN   146.57 (-0.31%)
TSLA   246.84 (+0.05%)
NVDA   480.96 (+0.58%)
NIO   7.24 (+0.42%)
BABA   74.86 (-2.45%)
AMD   124.39 (+1.95%)
T   16.26 (+0.49%)
F   10.63 (+2.51%)
MU   76.92 (+1.05%)
CGC   0.57 (+4.96%)
GE   119.02 (+0.14%)
DIS   92.82 (+0.35%)
AMC   7.18 (+7.16%)
PFE   30.06 (+1.25%)
PYPL   58.68 (+0.36%)
XOM   103.57 (-0.32%)
S&P 500   4,565.43 (+0.23%)
DOW   35,547.03 (+0.37%)
QQQ   390.93 (+0.19%)
AAPL   189.48 (-0.48%)
MSFT   378.78 (-1.02%)
META   333.51 (-1.62%)
GOOGL   135.53 (-1.22%)
AMZN   146.57 (-0.31%)
TSLA   246.84 (+0.05%)
NVDA   480.96 (+0.58%)
NIO   7.24 (+0.42%)
BABA   74.86 (-2.45%)
AMD   124.39 (+1.95%)
T   16.26 (+0.49%)
F   10.63 (+2.51%)
MU   76.92 (+1.05%)
CGC   0.57 (+4.96%)
GE   119.02 (+0.14%)
DIS   92.82 (+0.35%)
AMC   7.18 (+7.16%)
PFE   30.06 (+1.25%)
PYPL   58.68 (+0.36%)
XOM   103.57 (-0.32%)
S&P 500   4,565.43 (+0.23%)
DOW   35,547.03 (+0.37%)
QQQ   390.93 (+0.19%)
AAPL   189.48 (-0.48%)
MSFT   378.78 (-1.02%)
META   333.51 (-1.62%)
GOOGL   135.53 (-1.22%)
AMZN   146.57 (-0.31%)
TSLA   246.84 (+0.05%)
NVDA   480.96 (+0.58%)
NIO   7.24 (+0.42%)
BABA   74.86 (-2.45%)
AMD   124.39 (+1.95%)
T   16.26 (+0.49%)
F   10.63 (+2.51%)
MU   76.92 (+1.05%)
CGC   0.57 (+4.96%)
GE   119.02 (+0.14%)
DIS   92.82 (+0.35%)
AMC   7.18 (+7.16%)
PFE   30.06 (+1.25%)
PYPL   58.68 (+0.36%)
XOM   103.57 (-0.32%)
S&P 500   4,565.43 (+0.23%)
DOW   35,547.03 (+0.37%)
QQQ   390.93 (+0.19%)
AAPL   189.48 (-0.48%)
MSFT   378.78 (-1.02%)
META   333.51 (-1.62%)
GOOGL   135.53 (-1.22%)
AMZN   146.57 (-0.31%)
TSLA   246.84 (+0.05%)
NVDA   480.96 (+0.58%)
NIO   7.24 (+0.42%)
BABA   74.86 (-2.45%)
AMD   124.39 (+1.95%)
T   16.26 (+0.49%)
F   10.63 (+2.51%)
MU   76.92 (+1.05%)
CGC   0.57 (+4.96%)
GE   119.02 (+0.14%)
DIS   92.82 (+0.35%)
AMC   7.18 (+7.16%)
PFE   30.06 (+1.25%)
PYPL   58.68 (+0.36%)
XOM   103.57 (-0.32%)

UiPath Stock Price, News & Analysis (NYSE:PATH)

$19.91
+0.93 (+4.90%)
(As of 01:16 PM ET)
Compare
Today's Range
$19.32
$20.10
50-Day Range
$14.94
$18.96
52-Week Range
$10.98
$20.10
Volume
9.84 million shs
Average Volume
7.49 million shs
Market Capitalization
$11.28 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.84

UiPath MarketRank™ Stock Analysis

Analyst Rating
Hold
2.43 Rating Score
Upside/​Downside
1.0% Upside
$19.84 Price Target
Short Interest
Healthy
8.98% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.54mentions of UiPath in the last 14 days
Based on 13 Articles This Week
Insider Trading
Selling Shares
$4.78 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.28) to ($0.27) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.92 out of 5 stars

Business Services Sector

203rd out of 308 stocks

Prepackaged Software Industry

121st out of 199 stocks


PATH stock logo

About UiPath Stock (NYSE:PATH)

UiPath Inc. is a leading software company specializing in robotic process automation (RPA) technology. Headquartered in New York City, but founded in Bucharest, Romania, UiPath offers a comprehensive platform that automates repetitive tasks and enables businesses to operate more efficiently. The company was founded in 2005 by Romanian entrepreneurs Daniel Dines and Marius Tirca and has since grown to become a significant player in the RPA industry. UiPath has received numerous awards and accolades, including being named a leader in the Gartner Magic Quadrant for RPA Software in 2020.

UiPath's executive team is led by Chief Executive Officer and co-founder Daniel Dines, who has been with the company since its inception. Daniel is considered one of the pioneers of robotic process automation, helping start the industry. Mr. Dines contributes to his success in the industry by being relentless and constantly exposing himself to the industry's uncertainties. Other key management team members include Chief Financial Officer Ashim Gupta and Chief Marketing Officer Bobby Patrick. In 2021, UiPath announced that former Microsoft executive Tom Clancy would join as its new Senior Vice President of Learning.

UiPath has experienced significant growth in recent years, with revenue increasing exponentially since its inception. The company's net loss has been decreasing yearly. As of January 31, 2021, UiPath has cash, cash equivalents, and short-term investments capable of covering liabilities indicating that the company is working to keep control of its debt. UiPath's valuation has fluctuated since its IPO, with the company's market capitalization reaching a high of over $45 billion in May 2021 before falling to around $10 billion in Q4 of 2022. UiPath's price-to-sales ratio is higher than the industry average. Since its IPO in April 2021, UiPath's stock price has been volatile, with shares reaching a high of $90 in May 2021 before dropping to around $10 in November 2022. Since hitting its all-time low price, the stock has rebounded. Trading volume has also been relatively high, with an average of over 6 million shares traded per day.

The robotic process automation industry has experienced rapid growth in recent years as businesses seek to automate manual processes and increase efficiency. UiPath competes with several other robotic process automation providers, including Automation Anywhere, Blue Prism, and WorkFusion. In addition, the industry is subject to regulatory and political pressures, particularly around data privacy and security.

UiPath has identified several critical areas for growth, including expanding its product offerings to include artificial intelligence and machine learning capabilities and targeting new industries such as healthcare and financial services. The company has also been actively pursuing acquisitions, with recent purchases including Cloud Elements and ProcessGold.

As the robotic process automation industry continues to evolve, UiPath may face challenges from competitors who can offer similar or better technology at a lower cost. In addition, regulatory and political pressures may create uncertainty for the industry, which could impact UiPath's growth prospects.

PATH Stock Price History

PATH Stock News Headlines

Investing in AI? How about AI for investing (PATH)
Fintech is an area where AI promises to improve efficiency and aid capital gains to drive market-beating returns for investors.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Here's what Wall Street expects from UiPath's earnings report
UiPath (PATH) Q3 Earnings Report Preview: What To Look For
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
J.P. Morgan Reaffirms Their Hold Rating on UiPath (PATH)
UiPath: AI And Reaccelerating Growth Bode Well For 2024
UiPath: Correction Over; Outperformance Ahead
UiPath (PATH) to Release Earnings on Thursday
Better AI Software Stock: UiPath vs. Palantir
UiPath May Beat Expectations Again, Staying Expensive
UiPath (PATH) Laps the Stock Market: Here's Why
UiPath Inc Class A
See More Headlines
Receive PATH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UiPath and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/06/2023
Today
11/29/2023
Next Earnings (Confirmed)
11/30/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Fax
N/A
Employees
3,833
Year Founded
2005

Price Target and Rating

Average Stock Price Target
$19.84
High Stock Price Target
$27.50
Low Stock Price Target
$16.00
Potential Upside/Downside
+4.7%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
14 Analysts

Profitability

Net Income
$-328,350,000.00
Pretax Margin
-14.66%

Debt

Sales & Book Value

Annual Sales
$1.06 billion
Book Value
$3.45 per share

Miscellaneous

Free Float
390,879,000
Market Cap
$10.75 billion
Optionable
Not Optionable
Beta
0.60

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives















PATH Stock Analysis - Frequently Asked Questions

Should I buy or sell UiPath stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last twelve months. There are currently 8 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" PATH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PATH, but not buy additional shares or sell existing shares.
View PATH analyst ratings
or view top-rated stocks.

What is UiPath's stock price target for 2024?

14 Wall Street research analysts have issued twelve-month target prices for UiPath's stock. Their PATH share price targets range from $16.00 to $27.50. On average, they anticipate the company's share price to reach $19.84 in the next twelve months. This suggests that the stock has a possible downside of 0.3%.
View analysts price targets for PATH
or view top-rated stocks among Wall Street analysts.

How have PATH shares performed in 2023?

UiPath's stock was trading at $12.71 at the start of the year. Since then, PATH shares have increased by 56.6% and is now trading at $19.91.
View the best growth stocks for 2023 here
.

When is UiPath's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 30th 2023.
View our PATH earnings forecast
.

How can I listen to UiPath's earnings call?

UiPath will be holding an earnings conference call on Thursday, November 30th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were UiPath's earnings last quarter?

UiPath Inc. (NYSE:PATH) issued its quarterly earnings data on Wednesday, September, 6th. The healthcare company reported $0.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.05. The healthcare company earned $287.31 million during the quarter, compared to analyst estimates of $281.48 million. UiPath had a negative net margin of 15.47% and a negative trailing twelve-month return on equity of 7.49%. UiPath's revenue was up 18.6% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.18) earnings per share.

What guidance has UiPath issued on next quarter's earnings?

UiPath updated its third quarter 2024 earnings guidance on Wednesday, September, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $313.00 million-$318.00 million, compared to the consensus revenue estimate of $315.33 million.

When did UiPath IPO?

(PATH) raised $990 million in an initial public offering on Wednesday, April 21st 2021. The company issued 21,300,000 shares at $43.00-$50.00 per share. Morgan Stanley, JPMorgan, BofA Securities, Credit Suisse, Barclays and Wells Fargo Securities served as the underwriters for the IPO and SMBC Nikko, BMO Capital Markets, Mizuho Securities USA, KeyBanc Capital Markets, TD Securities (USA), Truist SecuritiesCowen, Evercore Group, Macquarie Capital (USA), Nomura, RBC Capital Markets, Canaccord Genuity, D. A. Davidson & Co., Oppenheimer & Co. and Needham & Co. were co-managers.

Who are UiPath's major shareholders?

UiPath's stock is owned by a number of institutional and retail investors. Top institutional shareholders include ARK Investment Management LLC (8.35%), Sumitomo Mitsui Trust Holdings Inc. (4.52%), FMR LLC (2.87%), Alkeon Capital Management LLC (1.43%), Senvest Management LLC (1.10%) and Accel Growth Fund IV Associates L.L.C. (1.08%). Insiders that own company stock include Ashim Gupta, Brad Brubaker, Daniel Dines, East Fund 2013 Sca Sic Digital, Hitesh Ramani, Kimberly Hammonds, Laela Sturdy, Philippe Botteri, Rich Wong, Ted Kummert and Thomas Neergaard Hansen.
View institutional ownership trends
.

How do I buy shares of UiPath?

Shares of PATH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does UiPath have any subsidiaries?
The following companies are subsidiares of UiPath: Cloud Elements, Cloud Elements Inc., CloudElements Technologies India Private Limited, MagnaView BV, ProcessGold A.G., ProcessGold B.V., ProcessGold International B.V., Re:infer, Shanghai Zhicheng Technology Co. Ltd., StepShot, The Conundrum IP LLC, UiPath AB, UiPath Australia Pty Ltd, UiPath Austria GmbH, UiPath Belgium BVBA, UiPath Brasil Consultoria Limitada, UiPath Business Solutions India Private Limited, UiPath Canada Operations Ltd., UiPath Denmark ApS, UiPath Finland Oy, UiPath France SAS, UiPath GMBH, UiPath Inc., UiPath Israel LTD, UiPath Italy SRL, UiPath Kabushiki Kaisha, UiPath Korea Ltd., UiPath Limited (Hong Kong), UiPath Ltd. (UK), UiPath Mexico S. DE R.L. DE C.V., UiPath Netherlands B.V., UiPath Netherlands Holding B.V., UiPath Norway AS, UiPath OOO, UiPath PTE LTD, UiPath Process Mining, UiPath Robotic Process Automation India Private Limited, UiPath SRL, UiPath South Africa (Pty) LTD, UiPath Switzerland GmbH, UiPath Ukraine LLC, and UiPath Ventures LLC.
Read More
This page (NYSE:PATH) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -